2% Lidocaine Hci Injection, Solution
Product Images NDC 51662-1231

13 FDA label images from Hf Acquisition Co. Llc, Dba Health First · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for 2% Lidocaine Hci (NDC 51662-1231). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Availability (Availability)

Availability (Availability)
A data table presenting Lidocaine Hydrochloride injection information with columns for volume (total lidocaine HCl), concentration in mg/mL, and pH. It includes two rows: one for direct intravenous injection (5 mL with 20 mg/mL concentration, pH 5.0 to 7.0) and one single-dose option (5 mL with 10 mg/mL concentration, pH 5.0 to 7.0).*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lidocaine hydrochloride monohydrate, showing the aromatic ring with two methyl groups and the amide linkage to a diethylaminoethyl side chain, including hydrochloride and water components.*
FDA Label Image

Syringe Box (5ml Syr Box)

Syringe Box (5ml Syr Box)
Packaging label for 2% Lidocaine HCI Injection, USP, 100 mg/5 mL in a 5 mL glass unit dose syringe with male luer lock adapter and 20-Gauge protected needle. The label includes usage instructions, handling cautions, and is labeled for intravenous use in cardiac arrhythmias. The product is manufactured by HF Acquisition Co. LLC, DBA Health First, with NDC 51662-1231.*
FDA Label Image

5ml Syringe Label (5ml Syringe Label)

5ml Syringe Label (5ml Syringe Label)
Label for 2% Lidocaine HCl Injection, USP, 100 mg/5 mL single-dose vial. The label includes a red highlighted section with the strength and concentration and dosage scale markings in mL. It notes that the product contains no preservatives, is sterile, nonpyrogenic, and intended for I.V. cardiac arrhythmia use. The manufacturer is Hospira, Inc., Lake Forest, IL, USA.*
FDA Label Image

Rfid Label (51662 1231 1 Rfid Label)

Rfid Label (51662 1231 1 Rfid Label)
Close-up of a barcode label on 2% LIDOCAINE HCI injection, solution, 20 mg/mL, distributed by HF Acquisition Co. LLC, DBA Health First, Mukilteo, WA. The label includes GS1 data matrix barcode, alphanumeric batch number, expiration date, and a note to see the manufacturer's insert.*
FDA Label Image

Serialized Label (51662 1231 1 Lidocaine 100mg Serialized Label On Box)

Serialized Label (51662 1231 1 Lidocaine 100mg Serialized Label On Box)
2% LIDOCAINE HCI injection, solution for intravenous use in a box labeled with 20 mg/mL strength and 100 mg total dosage. Distributed by HF Acquisition Co., LLC DBA Health First, Mukilteo, WA. The packaging includes storage instructions and needle safety warnings.*
FDA Label Image

Pouch Labeling (56112 1231 2 Pouch Labeling Final)

Pouch Labeling (56112 1231 2 Pouch Labeling Final)
Label for 2% LIDOCAINE HCl Injection USP, containing 100 mg/5 mL (20 mg/mL) in a 5 mL syringe. The label shows the NDC 51662-1231-2, lot number 123456, and expiration date 2030-01-01. The product is indicated for intravenous use and is manufactured by HF Acquisition Co., LLC, Mukilteo, WA 98275.*
FDA Label Image

Carton Labeling (51662 1231 2 Carton Label)

Carton Labeling (51662 1231 2 Carton Label)
Label for 2% Lidocaine HCl Injection, USP, 100 mg/5 mL (20 mg/mL) intravenous solution. The package is a 5 mL glass unit of use syringe with male luer lock adapter and 20-gauge protected needle by Hospira. It includes preparation instructions, drug identification, lot and expiration date fields, and a barcode on a predominantly pink and white background.*
FDA Label Image

Syringe Label (51662 1231 2 Syringe Label)

Syringe Label (51662 1231 2 Syringe Label)
2% Lidocaine HCl injection solution label showing 100 mg/5 mL (20 mg/mL) strength in a 5 mL single-dose vial. The label includes dosage strength, lot and expiration date placeholders, a volume scale, and distributor information by Hospira, Inc. The label also notes that it is sterile, nonpyrogenic, and for intravenous use.*
FDA Label Image

Case Labeling (51662 1231 3 Case Labeling Final)

Case Labeling (51662 1231 3 Case Labeling Final)
Label for 2% LIDOCAINE HCl Injection, USP 100 mg/5 mL (20 mg/mL) in a 5 mL syringe, case of 10 by HF Acquisition Co. LLC. The label includes NDC 51662-1231-3, lot number 123456, and expiration date 2030-01-01. Additional text outlines storage, sterility, and usage instructions.*
FDA Label Image

Rfid Label (51662 1231 3 Rfid)

Rfid Label (51662 1231 3 Rfid)
The image shows a white label on a plain background with black text featuring a barcode and a QR code. The label includes the National Drug Code (NDC) number 40351662123131, a date code of 230919, and the text "SEE MANUFACTURE'S INSERT DISTRIBUTED BY HF ACQUISITIONS CO., LLC MUKILTEO, WA 98275." The label appears to be for the 2% Lidocaine HCl injection solution, distributed by HF Acquisition Co., LLC.*
FDA Label Image

Carton Labeling (51662 1231 3 Carton Label)

Carton Labeling (51662 1231 3 Carton Label)
Packaging label for 2% Lidocaine HCl Injection, USP, 100 mg/5 mL (20 mg/mL) intravenous solution in a 5 mL glass unit of use syringe. The label indicates use for cardiac arrhythmias and features a male luer lock adapter and 20-gauge protected needle. Manufactured by HF Acquisition Co. LLC, DBA Health First and distributed by Hospira, Inc.*
FDA Label Image

Syringe Label (51662 1231 3 Syringe Label)

Syringe Label (51662 1231 3 Syringe Label)
Label for 2% Lidocaine HCl injection, USP, 100 mg/5 mL (20 mg/mL) solution in a 5 mL single-dose vial. Includes dosage concentration marked in red at the top, volume scale in mL, and medication information with NDC 0409-4903-11. Distributed by Hospira, Inc., Lake Forest, IL. Contains no preservatives, sterile and nonpyrogenic for intravenous use in cardiac arrhythmias. Expiration and lot number fields are indicated at the top.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.